(CercleFinance.com) – Spineway drops 4% after the publication by the company of implants and surgical instruments of a net result of -3.1 million euros for 2022, against -1.6 million the year previous year (excluding Spine Innovations), and an operating result of -3.2 million.
However, the gross margin rate on sales increased by 1.4 points to 69%, for an annual turnover of 7.4 million euros, an increase of 73% driven, among other things, by its historical customers, particularly in Latin America.
‘Building on its new strengths and solidly established, Spineway confirms its ambition to become the innovative player in France and internationally, the leader in less invasive treatments for the spine’, confirms the company.